Question 1

What are the main differences between the GORE® Hybrid Vascular Graft and the non-heparin bonded graft?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of Anti-platelet Factor 4/Heparin Antibodies in Hemodialysis Patients clinical trial (NCT02165761). Contact the study team or your healthcare provider for specific answers.

Question 2

How might this trial impact my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of Anti-platelet Factor 4/Heparin Antibodies in Hemodialysis Patients clinical trial (NCT02165761). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential risks and benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of Anti-platelet Factor 4/Heparin Antibodies in Hemodialysis Patients clinical trial (NCT02165761). Contact the study team or your healthcare provider for specific answers.

Question 4

Will I need to visit the clinic frequently if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of Anti-platelet Factor 4/Heparin Antibodies in Hemodialysis Patients clinical trial (NCT02165761). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of Anti-platelet Factor 4/Heparin Antibodies in Hemodialysis Patients clinical trial (NCT02165761). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there alternative treatments I should consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of Anti-platelet Factor 4/Heparin Antibodies in Hemodialysis Patients clinical trial (NCT02165761). Contact the study team or your healthcare provider for specific answers.

What this study is about